OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Models
(2)
Repository
BioModels
(2)
Publication Date
2019
(2)
IsPrivate
False
(2)
Release Date
2024
(1)
2021
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).
Not available
S-EPMC6118403
|
biostudies-literature
Cite
Effect of the Synthetic Method on the Properties of Ni-Based Hydrogen Oxidation Catalysts.
Not available
S-EPMC8153405
|
biostudies-literature
Cite
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment.
Not available
S-EPMC10770342
|
biostudies-literature
Cite
Cardiomyocyte Telomere Damage by ROS without Cell Division
No description
2019-02-14
|
MODEL1608250001
|
BioModels
Cite
Cardiomyocyte Telomere Damage
No description
2019-02-14
|
MODEL1608250000
|
BioModels
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets